Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, UPM Serdang, Selangor, Malaysia.
Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia.
BMC Complement Med Ther. 2021 Jan 14;21(1):35. doi: 10.1186/s12906-020-03200-2.
Water-soluble, but not lipid-soluble, extract of Dicranopteris linearis leaves has been proven to possess hepatoprotective activity. The present study aimed to validate the hepatoprotective and antioxidant activities, and phytoconstituents of lipid-soluble (chloroform) extract of D. linearis leaves.
The extract of D. linearis leaves (CEDL; 50, 250 and 500 mg/kg) was orally administered to rats for 7 consecutive days followed by the oral administration of 3 g/kg PCM to induce liver injury. Blood was collected for liver function analysis while the liver was obtained for histopathological examination and endogenous antioxidant activity determination. The extract was also subjected to antioxidant evaluation and phytochemicals determination via phytochemical screening, HPLC and UPLC-HRMS analyses.
CEDL exerted significant (p < 0.05) hepatoprotective activity at 250 and 500 mg/kg and significantly (p < 0.05) reversed the PCM-induced decrease in rat's liver endogenous antioxidant (catalase and superoxide dismutase) level. CEDL possessed a high antioxidant capacity when measured using the ORAC assay, but a low total phenolic content value and radical scavenging activity as confirmed via several radical scavenging assays, which might be attributed particularly to the presence of triterpenes. Phytochemicals screening demonstrated the presence of triterpenes and flavonoids, while UPLC-HRMS analysis showed the presence of polyphenols belonging to the hydroxybenzoic acids, hydroxycinammates and flavonoid groups.
Lipid-soluble bioactive compounds of CEDL demonstrated hepatoprotective effect against PCM intoxication partly via the modulation of the endogenous antioxidant defense system, and exerted high antioxidant capacity. Further investigation is warranted to identify the potential hepatoprotective leads from CEDL for future drug development.
已证实,水不溶性但脂溶性的贯众叶片提取物具有保肝活性。本研究旨在验证贯众叶片脂溶性(氯仿)提取物的保肝和抗氧化活性及植物成分。
贯众叶片提取物(CEDL;50、250 和 500mg/kg)连续 7 天经口给予大鼠,随后经口给予 3g/kg 对乙酰氨基酚(PCM)诱导肝损伤。收集血液用于肝功能分析,同时获取肝脏进行组织病理学检查和内源性抗氧化活性测定。还通过植物化学成分筛查、HPLC 和 UPLC-HRMS 分析对提取物进行抗氧化评价和植物化学成分测定。
CEDL 在 250 和 500mg/kg 时表现出显著的(p<0.05)保肝活性,并显著(p<0.05)逆转了 PCM 诱导的大鼠肝脏内源性抗氧化剂(过氧化氢酶和超氧化物歧化酶)水平的降低。CEDL 的 ORAC 测定抗氧化能力高,但几种自由基清除测定法证实总酚含量值和自由基清除活性低,这可能特别归因于三萜的存在。植物化学成分筛查显示存在三萜和类黄酮,而 UPLC-HRMS 分析显示存在属于羟基苯甲酸、羟基肉桂酸和类黄酮组的多酚类物质。
CEDL 的脂溶性生物活性化合物对 PCM 中毒具有保肝作用,部分通过调节内源性抗氧化防御系统,发挥高抗氧化能力。有必要进一步研究以确定 CEDL 中具有潜在保肝作用的先导化合物,用于未来的药物开发。